BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Colagrande S, Inghilesi AL, Aburas S, Taliani GG, Nardi C, Marra F. Challenges of advanced hepatocellular carcinoma. World J Gastroenterol 2016; 22(34): 7645-7659 [PMID: 27678348 DOI: 10.3748/wjg.v22.i34.7645]
URL: https://www.wjgnet.com/1948-5182/full/v22/i34/7645.htm
Number Citing Articles
1
Zhixin Wang, Kai Qu, Lei Zhou, Li Ren, Bin Ren, Fandi Meng, Wenhao Yu, Haijiu Wang, Haining Fan. Apaf1 nanoLuc biosensors identified lentinan as a potent synergizer of cisplatin in targeting hepatocellular carcinoma cellsBiochemical and Biophysical Research Communications 2021; 577: 45 doi: 10.1016/j.bbrc.2021.08.030
2
Guolin Chen, Shanshan Mo, Di Yuan, Tao Huang. Upregulation Mitochondrial Carrier 1 (MTCH1) Is Associated with Cell Proliferation, Invasion, and Migration of Liver Hepatocellular CarcinomaBioMed Research International 2021; 2021: 1 doi: 10.1155/2021/9911784
3
Zheyuan Wang, Zhiheng Shi, Lu Zhang, Huihan Zhang, Yawu Zhang. Profilin 1, negatively regulated by microRNA-19a-3p, serves as a tumor suppressor in human hepatocellular carcinomaPathology - Research and Practice 2019; 215(3): 499 doi: 10.1016/j.prp.2018.12.012
4
Muntadher Jihad, İdil Yet. Multiomics Integration at Single-Cell Resolution Using Bayesian Networks: A Case Study in Hepatocellular CarcinomaOMICS: A Journal of Integrative Biology 2023; 27(1): 24 doi: 10.1089/omi.2022.0170
5
Ashwaq Alolyan, Kanan Alshammari, Mohammad Arabi, Ahmed Alshehri, Hamad Alsuhaibani, Fahad Ibnshamsah, Abdullah Alsharm, Mervat Mahrous, Adnan Al Zanbagi, Mazen Hassanain, Shouki Bazarbashi. Treatment Patterns and Recommendations for Improving the Management of Hepatocellular Carcinoma in Saudi ArabiaJournal of Hepatocellular Carcinoma 2024; : 349 doi: 10.2147/JHC.S442842
6
Zhe Tang, Muxing Kang, Bo Zhang, Jianke Chen, Heqing Fang, Qin Ye, Biao Jiang, Yulian Wu. Advantage of Sorafenib Combined with Radiofrequency Ablation for Treatment of Hepatocellular CarcinomaTumori Journal 2017; 103(3): 286 doi: 10.5301/tj.5000585
7
Yan Xia, Xianhao Liu, Beibei Liu, Xiaoshi Zhang, Geng Tian. Enhanced antitumor activity of combined megestrol acetate and arsenic trioxide treatment in liver cancer cellsExperimental and Therapeutic Medicine 2018;  doi: 10.3892/etm.2018.5905
8
Li-Wei Qiu, Yi-Fei Liu, Xiao-Qing Cao, Yan Wang, Xiao-Hong Cui, Xian Ye, Shuo-Wen Huang, Hong-Jun Xie, Hai-Jian Zhang. Annexin A2 promotion of hepatocellular carcinoma tumorigenesis <i>via</i> the immune microenvironmentWorld Journal of Gastroenterology 2020; 26(18): 2126-2137 doi: 10.3748/wjg.v26.i18.2126
9
Jing Bai, Ziqi Liu, Jiang Liu, Saihang Zhang, Yuan Tian, Yueshan Zhang, Leiming Ren, Dezhi Kong. Mitochondrial metabolic study guided by proteomics analysis in hepatocellular carcinoma cells surviving long-term incubation with the highest dose of sorafenibAging 2019; 11(24): 12452 doi: 10.18632/aging.102582
10
Wenfang Xu, Wenke Guo, Ping Lu, Duan Ma, Lei Liu, Fudong Yu. Identification of an autophagy-related gene signature predicting overall survival for hepatocellular carcinomaBioscience Reports 2021; 41(1) doi: 10.1042/BSR20203231
11
Chaopin Yang, Jinqi You, Qiuzhong Pan, Yan Tang, Liming Cai, Yue Huang, Jiamei Gu, Yizhi Wang, Xinyi Yang, Yufei Du, Dijun Ouyang, Hao Chen, Haoran Zhong, Yongqiang Li, Jieying Yang, Yulong Han, Fengze Sun, Yuanyuan Chen, Qijing Wang, Desheng Weng, Zhongqiu Liu, Tong Xiang, Jianchuan Xia. Targeted delivery of a PD-1-blocking scFv by CD133-specific CAR-T cells using nonviral Sleeping Beauty transposition shows enhanced antitumour efficacy for advanced hepatocellular carcinomaBMC Medicine 2023; 21(1) doi: 10.1186/s12916-023-03016-0
12
Artificial Intelligence, Machine Learning, and Deep Learning in Precision Medicine in Liver Diseases2023; : 109 doi: 10.1016/B978-0-323-99136-0.00015-5
13
María Julia Martínez, Adriana Balbina Andreu, Luciana Barbini. Cytotoxic activity of Solanum tuberosum polyphenolic extracts in human hepatocarcinoma cells is mediated by apoptosis and autophagyJournal of Food Science 2022; 87(12): 5303 doi: 10.1111/1750-3841.16366
14
Junfeng Wang, Jianying Lou, Lei Fu, Qu Jin. An independent poor-prognosis subtype of hepatocellular carcinoma based on the tumor microenvironmentJournal of International Medical Research 2021; 49(2): 030006052098064 doi: 10.1177/0300060520980646
15
Zhi-Gang Gong, Weijie Zhao, Jianbing Zhang, Xi Wu, Jing Hu, Guo-Chang Yin, Yong-Jiang Xu. Metabolomics and eicosanoid analysis identified serum biomarkers for distinguishing hepatocellular carcinoma from hepatitis B virus-related cirrhosisOncotarget 2017; 8(38): 63890 doi: 10.18632/oncotarget.19173
16
Louie Semaan, Qingning Zeng, Yong Lu, Yi Zhang, Mehdi Mohamad Zreik, Mohamad Baqer Chamseddine, Michael Chopp, Zheng Gang Zhang, Dilip Moonka. MicroRNA-214 enriched exosomes from human cerebral endothelial cells (hCEC) sensitize hepatocellular carcinoma to anti-cancer drugsOncotarget 2021; 12(3): 185 doi: 10.18632/oncotarget.27879
17
Stefano Colagrande, Linda Calistri, Giulia Grazzini, Cosimo Nardi, Simone Busoni, Giovanni Morana, Luigi Grazioli. MRI features of primary hepatic lymphomaAbdominal Radiology 2018; 43(9): 2277 doi: 10.1007/s00261-018-1476-5
18
Tung-Ho Wu, Tung-Yi Lin, Pei-Ming Yang, Wen-Tai Li, Chau-Ting Yeh, Tai-Long Pan. Scutellaria baicalensis Induces Cell Apoptosis and Elicits Mesenchymal–Epithelial Transition to Alleviate Metastatic Hepatocellular Carcinoma via Modulating HSP90βInternational Journal of Molecular Sciences 2024; 25(5): 3073 doi: 10.3390/ijms25053073
19
Carmen Berasain, André Lechel. Targeting the correct target in HCCGut 2017; 66(8): 1352 doi: 10.1136/gutjnl-2016-313462
20
James Yu, Robin Park, Richard Kim. Promising Novel Biomarkers for Hepatocellular Carcinoma: Diagnostic and Prognostic InsightsJournal of Hepatocellular Carcinoma 2023; : 1105 doi: 10.2147/JHC.S341195
21
Bao-Min Shi, Wen Lu, Kun Ji, Yu-Feng Wang, Shuai Xiao, Xiu-Yan Wang. Study on the value of serum miR-106b for the early diagnosis of hepatocellular carcinomaWorld Journal of Gastroenterology 2017; 23(20): 3713-3720 doi: 10.3748/wjg.v23.i20.3713
22
Ya-Lin Kong, Jin-Jin Sun, Hong-Yi Zhang, Ying Xing, Cheng Wang, Yang Liu, Xiao-Jun He, Ling-Hong Kong, Cheng-Li Liu. Clinical evaluation of percutaneous endovascular radiofrequency ablation for portal vein tumor thrombus: experience in 120 patientsSurgical Endoscopy 2023; 37(2): 1173 doi: 10.1007/s00464-022-09639-3
23
Yue Ming, Bin Li, Ruoqiu Fu, Haiyan Xing, Yao Liu, Dongyu Duan, Ziwei Li, Li Li, Rui Ni, Jing Xu, Chen Li, Mingfeng Xiang, Hongyu Song, Jianhong Chen. Bovine Serum Albumin Nanoparticle-Mediated Delivery of Sorafenib for Improving Hepatocellular Carcinoma TherapyJournal of Nanoscience and Nanotechnology 2021; 21(10): 5075 doi: 10.1166/jnn.2021.19362
24
Francisco Tustumi, Fabricio Ferreira Coelho, Daniel de Paiva Magalhães, Sérgio Silveira Júnior, Vagner Birk Jeismann, Gilton Marques Fonseca, Jaime Arthur Pirola Kruger, Luiz Augusto Carneiro D'Albuquerque, Paulo Herman. Treatment of hepatocellular carcinoma with macroscopic vascular invasion: A systematic review and network meta-analysisTransplantation Reviews 2023; 37(3): 100763 doi: 10.1016/j.trre.2023.100763
25
María Paula Ceballos, Juan Pablo Rigalli, Lucila Inés Ceré, Mariana Semeniuk, Viviana Alicia Catania, María Laura Ruiz. ABC Transporters: Regulation and Association with Multidrug Resistance in Hepatocellular Carcinoma and Colorectal CarcinomaCurrent Medicinal Chemistry 2019; 26(7): 1224 doi: 10.2174/0929867325666180105103637
26
Beom-Hui Lee, Dong-Shik Lee, Chan Woo Cho, Sung-Su Yun. Role and limitation of neoadjuvant hepatic arterial infusion chemotherapy in advanced hepatocelluar carcinoma patients with Child-Pugh class AWorld Journal of Surgical Oncology 2019; 17(1) doi: 10.1186/s12957-019-1685-6
27
Mostafa M. Ghorab, Fatma A. Ragab, Helmy I. Heiba, Marwa G. El-Gazzar, Mostafa G.M. El-Gazzar. Novel thioureido-benzenesulfonamide derivatives with enaminone linker as potent anticancer, radiosensitizers and VEGFR2 inhibitorsBioorganic & Medicinal Chemistry Letters 2018; 28(9): 1464 doi: 10.1016/j.bmcl.2018.03.089
28
Minho Noh, Beom Kyung Kim, Seung Up Kim. Advanced Stage Hepatocellular Carcinoma Successfully Treated with Liver-directed Concurrent Chemoradiotherapy and Sequential Transarterial Radio-embolizationJournal of Liver Cancer 2021; 21(1): 97 doi: 10.17998/jlc.21.1.97
29
Mohammad Roshani, Arya Rezaian-Isfahni, Mohammad Hassan Lotfalizadeh, Negar Khassafi, Mohammad Hassan Jafari Najaf Abadi, Majid Nejati. Metal nanoparticles as a potential technique for the diagnosis and treatment of gastrointestinal cancer: a comprehensive reviewCancer Cell International 2023; 23(1) doi: 10.1186/s12935-023-03115-1
30
Huarong Chen, Jun Yu. Liver Diseases2020; : 85 doi: 10.1007/978-3-030-24432-3_8
31
Dongping Li, Xiahui Lin, Jiale Li, Xinyi Liu, Feng Zhang, Wenqing Tang, Si Zhang, Ling Dong, Ruyi Xue. Eleven metabolism‑related genes composed of Stard5 predict prognosis and contribute to EMT phenotype in HCCCancer Cell International 2023; 23(1) doi: 10.1186/s12935-023-03097-0
32
Shakira Hoque, Christy Kim, Mihir Desai, Pram Sirimana, Malin Katarina Schumacher, Sri Jasti, Mostafa Abasseri, Oliver M.Fisher, Francis Chu, Suhrid Lodh, Natalie Collier, Winston Liauw, Piotr Milkiewicz, Amany Zekry. Gastrointestinal Oncology ‐ A Critical Multidisciplinary Team Approach 2e2024; : 321 doi: 10.1002/9781119756422.ch18
33
Wenfang Xu, Zhen Chen, Gang Liu, Yuping Dai, Xuanfu Xu, Duan Ma, Lei Liu, John Patrick Vanden Heuvel. Identification of a Potential PPAR-Related Multigene Signature Predicting Prognosis of Patients with Hepatocellular CarcinomaPPAR Research 2021; 2021: 1 doi: 10.1155/2021/6642939
34
Liang Peng, Rong Ye, Xiansen Zhu, Yuankang Xie, Baiyin Zhong, Yao Liu, Heping Li, Binhui Xie, Arturo Ortega. LINC02273 Promotes Hepatocellular Carcinoma Progression via Retaining β-Catenin in the Nucleus to Augment Wnt SignalingBioMed Research International 2022; 2022: 1 doi: 10.1155/2022/9631036
35
Kumardeep Chaudhary, Olivier B. Poirion, Liangqun Lu, Lana X. Garmire. Deep Learning–Based Multi-Omics Integration Robustly Predicts Survival in Liver CancerClinical Cancer Research 2018; 24(6): 1248 doi: 10.1158/1078-0432.CCR-17-0853
36
Cheng Jin, Ling Bai, Lemin Lin, Shuangquan Wang, Xiaolong Yin. Paclitaxel-loaded nanoparticles decorated with bivalent fragment HAb18 F(ab’)2 and cell penetrating peptide for improved therapeutic effect on hepatocellular carcinomaArtificial Cells, Nanomedicine, and Biotechnology 2018; 46(5): 1076 doi: 10.1080/21691401.2017.1360325
37
Xiaofei Li, Daofu Zhang, Shan Guan, Weiwei Ye, Liwen Liu, Lianqing Lou. Efficacy of anti-VEGF agents in the treatment of elderly hepatocellular carcinoma: a systematic reviewOncotarget 2017; 8(54): 93179 doi: 10.18632/oncotarget.21452
38
Zaiba S. Dawood, Zachary J. Brown, Laura Alaimo, Henrique A. Lima, Chanza Shaikh, Erryk S. Katayama, Muhammad M. Munir, Zorays Moazzam, Yutaka Endo, Selamawit Woldesenbet, Timothy M. Pawlik. Comparison of tumor response and outcomes of patients with hepatocellular carcinoma after multimodal treatment including immune checkpoint inhibitors – a systematic review and meta-analysisHPB 2024;  doi: 10.1016/j.hpb.2024.02.003
39
Perry B. Hammond, Jonathan R. Mark, Rebecca R. Benefiel. Imperial Epistaxis and Edema: Insights into the Death of the Roman Emperor HadrianEar, Nose & Throat Journal 2024; 103(3): 137 doi: 10.1177/01455613211042120
40
Zheng Dong, Ruizhao Qi, Xiaodong Guo, Xin Zhao, Yinyin Li, Zhen Zeng, Wenlin Bai, Xiujuan Chang, Liyan Hao, Yan Chen, Min Lou, Zhiwei Li, Yinying Lu. MiR-223 modulates hepatocellular carcinoma cell proliferation through promoting apoptosis via the Rab1-mediated mTOR activationBiochemical and Biophysical Research Communications 2017; 483(1): 630 doi: 10.1016/j.bbrc.2016.12.091
41
Tsinat Berhane, Anja Holm, Kasper Thystrup Karstensen, Andreas Petri, Mirolyuba Simeonova Ilieva, Henrik Krarup, Mogens Vyberg, Marianne Bengtson Løvendorf, Sakari Kauppinen. Knockdown of the long noncoding RNA PURPL induces apoptosis and sensitizes liver cancer cells to doxorubicinScientific Reports 2022; 12(1) doi: 10.1038/s41598-022-23802-9
42
Weijian Sun, Bin He, Beng Yang, Wendi Hu, Shaobing Cheng, Heng Xiao, Zhengjie Yang, Xiaoyu Wen, Lin Zhou, Haiyang Xie, Xian Shen, Jian Wu, Shusen Zheng. Genome-wide CRISPR screen reveals SGOL1 as a druggable target of sorafenib-treated hepatocellular carcinomaLaboratory Investigation 2018; 98(6): 734 doi: 10.1038/s41374-018-0027-6
43
Amr M. Shugaa Addin, Randa M. Talaat, Moustafa A. Sakr, Manal O. El Hamshary, Mohamed K. Khalifa, Ghada M. Nasr. Identification of the somatic mutations of SMAD4 among HCC Egyptian patients using NGSGene Reports 2022; 26: 101478 doi: 10.1016/j.genrep.2021.101478
44
Jean-Frédéric Blanc, Caroline Laurendeau, Marie de Zélicourt, Manel Dhaoui, Nadia Kelkouli, Francis Fagnani, Philippe Mathurin, Benjamin Chan. Treatment Patterns and Survival in Patients with Intermediate, Advanced, or Terminal Stage of Hepatocellular Carcinoma in France over the Period 2015-2017: A Real-Life StudyGastroHep 2023; 2023: 1 doi: 10.1155/2023/5800168
45
S. Colagrande, L. Calistri, C. Campani, G. Dragoni, C. Lorini, C. Nardi, A. Castellani, F. Marra. CT volume of enhancement of disease (VED) can predict the early response to treatment and overall survival in patients with advanced HCC treated with sorafenibEuropean Radiology 2021; 31(3): 1608 doi: 10.1007/s00330-020-07171-3
46
Tingze Feng, Tianzhi Wu, Yanxia Zhang, Lang Zhou, Shanshan Liu, Lin Li, Ming Li, Erqiang Hu, Qianwen Wang, Xiaocong Fu, Li Zhan, Zijing Xie, Wenqin Xie, Xianying Huang, Xuan Shang, Guangchuang Yu. Stemness Analysis Uncovers That The Peroxisome Proliferator-Activated Receptor Signaling Pathway Can Mediate Fatty Acid Homeostasis In Sorafenib-Resistant Hepatocellular Carcinoma CellsFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.912694
47
M. S. Chesnokov, O. M. Krivtsova, P. A. Skovorodnikova, A. S. Makarova, I. F. Kustova, M. D. Logacheva, A. A. Penin, A. V. Klepikova, D. A. Shavochkina, N. E. Kudashkin, E. A. Moroz, Y. I. Patyutko, E. A. Kotelnikova, N. L. Lazarevich. Transcriptome-based identification of PDGFA as a candidate secreted biomarker for hepatocellular carcinomaBiopolymers and Cell 2016; 32(6): 418 doi: 10.7124/bc.000939
48
Ayana R Kumar, Anitha L, Bhagyalakshmi Nair, Bijo Mathew, Sinoy Sugunan, Lekshmi R. Nath. Decoding the Mechanism of Drugs of Heterocyclic Nature against Hepatocellular CarcinomaAnti-Cancer Agents in Medicinal Chemistry 2023; 23(8): 882 doi: 10.2174/1871520622666220418115310
49
Mai-Huong Thi Ngo, Han-Yin Jeng, Yung-Che Kuo, Josephine Diony Nanda, Ageng Brahmadhi, Thai-Yen Ling, Te-Sheng Chang, Yen-Hua Huang. The Role of IGF/IGF-1R Signaling in Hepatocellular Carcinomas: Stemness-Related Properties and Drug ResistanceInternational Journal of Molecular Sciences 2021; 22(4): 1931 doi: 10.3390/ijms22041931
50
Xinlun Dai, Shupeng Wang, Chunyuan Niu, Bai Ji, Yahui Liu. Overview of Current Progress in Immune Checkpoint Inhibitor Therapy for Advanced Hepatocellular CarcinomaTechnology in Cancer Research & Treatment 2020; 19: 153303382094748 doi: 10.1177/1533033820947486
51
Imam Waked, Sherif Alsammany, Sayed Hammad Tirmazy, Kakil Rasul, Jafar Bani‐Issa, Wael Abdel‐Razek, Ashraf Omar, Amr Shafik, Salem Eid, Amr Abdelaal, Ahmed Hosni, Gamal Esmat. Multidisciplinary consensus recommendations for management of hepatocellular carcinoma in Middle East and North Africa regionLiver International 2023; 43(10): 2062 doi: 10.1111/liv.15685
52
Ginny Jacobs, Deborah A. Boyle, Hashem B. El‐Serag, Robert J. Lewandowski, Stacey M. Stein, Patrice Lazure, Pam McFadden. Clinical care in hepatocellular carcinoma: A mixed methods assessment of experiences and challenges of oncology professionalsCancer Medicine 2023; 12(3): 3670 doi: 10.1002/cam4.5216
53
Yasi Pan, Huarong Chen, Jun Yu. Biomarkers in Hepatocellular Carcinoma: Current Status and Future PerspectivesBiomedicines 2020; 8(12): 576 doi: 10.3390/biomedicines8120576
54
Shant Qinxiang Sin, Chakrabhavi Dhananjaya Mohan, Robby Miguel Wen-Jing Goh, Mingliang You, Siddaiah Chandra Nayak, Lu Chen, Gautam Sethi, Kanchugarakoppal Subbegowda Rangappa, Lingzhi Wang. Hypoxia signaling in hepatocellular carcinoma: Challenges and therapeutic opportunitiesCancer and Metastasis Reviews 2023; 42(3): 741 doi: 10.1007/s10555-022-10071-1
55
Shen Hu, Yan Zhu, Xiangyang Xia, Xiaobo Xu, Fen Chen, Xudong Miao, Xinmei Chen. Ginsenoside Rg3 Prolongs Survival of the Orthotopic Hepatocellular Carcinoma Model by Inducing Apoptosis and Inhibiting AngiogenesisAnalytical Cellular Pathology 2019; 2019: 1 doi: 10.1155/2019/3815786
56
Mohammad Ashraful Alam, Sheikh Mohammad Noor-E-Alam, Md Abdur Rahim, Faiz Ahmad Khondaker, Ahmed Lutful Moben, Jhumur Ghosh, Md Sakirul Islam Khan. Treatment by Transarterial Chemoembolization and Sorafenib for Hepatocellular Carcinoma vs Advanced Hepatocellular Carcinoma in Bangladesh: A Real-life Situation Euroasian Journal of Hepato-Gastroenterology 2019; 9(2): 63 doi: 10.5005/jp-journals-10018-1300
57
Valentina Leone, Adnan Ali, Achim Weber, Darjus Felix Tschaharganeh, Mathias Heikenwalder. Liver Inflammation and Hepatobiliary CancersTrends in Cancer 2021; 7(7): 606 doi: 10.1016/j.trecan.2021.01.012
58
Yan Zhou, Lijuan Liu, Youyi Liu, Ping Zhou, Qiujin Yan, Honglian Yu, Xiaobei Chen, Fan Zhu. Implication of human endogenous retrovirus W family envelope in hepatocellular carcinoma promotes MEK/ERK-mediated metastatic invasiveness and doxorubicin resistanceCell Death Discovery 2021; 7(1) doi: 10.1038/s41420-021-00562-5
59
Zhou-wei Xu, Shang-xue Yan, Hua-xun Wu, Ying Zhang, Wei Wei. Angiotensin II and tumor necrosis factor-α stimulate the growth, migration and invasion of BEL-7402 cells via down-regulation of GRK2 expressionDigestive and Liver Disease 2019; 51(2): 263 doi: 10.1016/j.dld.2018.06.007
60
Yuqian Mo, Zhilin Zou, Erbao Chen. Targeting ferroptosis in hepatocellular carcinomaHepatology International 2024; 18(1): 32 doi: 10.1007/s12072-023-10593-y
61
Weibo Du, Wenbiao Chen, Zheyue Shu, Dairong Xiang, Kefan Bi, Yingfeng Lu, Xujun Zhang, Lanjuan Li, Hongyan Diao. Identification of prognostic biomarkers of hepatocellular carcinoma via long noncoding RNA expression and copy number alterationsEpigenomics 2020; 12(15): 1303 doi: 10.2217/epi-2019-0385
62
Pei-Yi Chu, Shiao-Lin Tung, Kuo-Wang Tsai, Fang-Ping Shen, Shih-Hsuan Chan. Identification of the Novel Oncogenic Role of SAAL1 and Its Therapeutic Potential in Hepatocellular CarcinomaCancers 2020; 12(7): 1843 doi: 10.3390/cancers12071843
63
Amanpreet Brar, Alice Zhu, Cristina Baciu, Divya Sharma, Wei Xu, Ani Orchanian‐Cheff, Bo Wang, Jüri Reimand, Robert Grant, Mamatha Bhat. Development of diagnostic and prognostic molecular biomarkers in hepatocellular carcinoma using machine learning: A systematic reviewLiver Cancer International 2022; 3(4): 141 doi: 10.1002/lci2.66
64
Marta Campos, Isabel Candelária, Nickolas Papanikolaou, Adélia Simão, Carlos Ferreira, Georgios C. Manikis, Filipe Caseiro-Alves. Perfusion Magnetic Resonance as a Biomarker for Sorafenib-Treated Advanced Hepatocellular Carcinoma: A Pilot StudyGE - Portuguese Journal of Gastroenterology 2019; 26(4): 260 doi: 10.1159/000493351
65
Eric Nguyen-Khac, Pierre Nahon, Olivier Ganry, Hajer Ben Khadhra, Philippe Merle, Giuliana Amaddeo, Nathalie Ganne-Carrie, Christine Silvain, Jean-Marie Peron, Philippe Mathurin, Rodolphe Anty, Thomas Uguen, Thomas Decaens, Ghassan Riachi, Mohamed Bouattour, Aurore Baron, Jean-Pierre Bronowicki, Georges-Philippe Pageaux, Olivier Rosmorduc, Gérard Ducournau, Mélina Gilberg, Alexandre Tanang, Julien Dupin, Anika Gilbert-Marceau, Jean-Frédéric Blanc. Unresectable hepatocellular carcinoma at dawn of immunotherapy era: real-world data from the French prospective CHIEF cohortEuropean Journal of Gastroenterology & Hepatology 2023; 35(10): 1168 doi: 10.1097/MEG.0000000000002546
66
Yao Wang, Meixia Chen, Zhiqiang Wu, Chuan Tong, Hanren Dai, Yelei Guo, Yang Liu, Jianhua Huang, Haiyan Lv, Can Luo, Kai-chao Feng, Qing-ming Yang, Xiao-lei Li, Weidong Han. CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trialOncoImmunology 2018; 7(7): e1440169 doi: 10.1080/2162402X.2018.1440169
67
Gautham Ramesh, Shubhankar Das, Satish Rao Bola Sadashiva. Berberine, a natural alkaloid sensitizes human hepatocarcinoma to ionizing radiation by blocking autophagy and cell cycle arrest resulting in senescenceJournal of Pharmacy and Pharmacology 2020; 72(12): 1893 doi: 10.1111/jphp.13354
68
Jing Du, Ye Mao, Ming Liu, Yan Tie, Hai Huang, Jian Zhao, Zhongzheng Xiang, Di Luo. Dose age affect the efficacy of molecular targeted agents in the treatment of hepatocellular carcinoma: a systematic review and meta-analysisOncotarget 2017; 8(60): 102413 doi: 10.18632/oncotarget.22061
69
Xiongfeng Pan, Atipatsa C Kaminga, Shi Wu Wen, Aizhong Liu. Chemokines in hepatocellular carcinoma: a meta-analysisCarcinogenesis 2020; 41(12): 1682 doi: 10.1093/carcin/bgaa106
70
Yang Liu, Xiang Wang, Xingzhi Zeng, Yinghua Wu, Xinrong Liu, Juan Tan, Xiaoyan Li. Bioinformatics-based analysis of SUMOylation-related genes in hepatocellular carcinoma reveals a role of upregulated SAE1 in promoting cell proliferationOpen Medicine 2022; 17(1): 1183 doi: 10.1515/med-2022-0510
71
Gillian M. Keating. Sorafenib: A Review in Hepatocellular CarcinomaTargeted Oncology 2017; 12(2): 243 doi: 10.1007/s11523-017-0484-7
72
Xinyu Gu, Jun Guan, Jia Xu, Qiuxian Zheng, Chao Chen, Qin Yang, Chunhong Huang, Gang Wang, Haibo Zhou, Zhi Chen, Haihong Zhu. Model based on five tumour immune microenvironment-related genes for predicting hepatocellular carcinoma immunotherapy outcomesJournal of Translational Medicine 2021; 19(1) doi: 10.1186/s12967-020-02691-4
73
Feng Wang, Jun Wang, Linlin Ju, Lin Chen, Weihua Cai, Jialin Yang. Diagnostic and prognostic potential of serum miR-132/212 cluster in patients with hepatocellular carcinomaAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine 2018; 55(5): 576 doi: 10.1177/0004563218755815
74
Xiaoxuan Liu, Lin Zhu, Jingjing Ma, Xinxiao Qiao, Dunwan Zhu, Lanxia Liu, Xigang Leng. Target-specific delivery of siRNA into hepatoma cells’ cytoplasm by bifunctional carrier peptideDrug Delivery and Translational Research 2017; 7(1): 147 doi: 10.1007/s13346-016-0348-1
75
Seung-Hun Kim, Wen-Hsing Wang, Jing-Ping Wang, Chang-Heng Hsieh, Kang Fang. Teroxirone suppresses growth and motility of human hepatocellular carcinoma cellsBiomedicine & Pharmacotherapy 2018; 99: 997 doi: 10.1016/j.biopha.2018.01.157
76
Ali Alqahtani, Zubair Khan, Abdurahman Alloghbi, Tamer S. Said Ahmed, Mushtaq Ashraf, Danae M. Hammouda. Hepatocellular Carcinoma: Molecular Mechanisms and Targeted TherapiesMedicina 2019; 55(9): 526 doi: 10.3390/medicina55090526
77
Mostafa Abasseri, Shakira Hoque, BA Slavica Kochovska, Kim Caldwell, Linda Sheahan, Amany Zekry. Barriers to palliative care in hepatocellular carcinoma: A review of the literatureJournal of Gastroenterology and Hepatology 2023; 38(7): 1047 doi: 10.1111/jgh.16107
78
Juhua Zhuang, Saifei He, Guoyu Wang, Guangdong Wang, Jing Ni, Suiliang Zhang, Ying Ye, Wei Xia. Long Noncoding RNA FGFR3-AS1 Promotes Hepatocellular Carcinoma Carcinogenesis via Modulating the PI3K/AKT PathwayOncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2018; 26(8): 1257 doi: 10.3727/096504018X15172756878992
79
Peng Zhang, Jiang-Hua Zhao, Lin Chen, Zhao-Lian Bian, Lin-Ling Ju, Hui-Xuan Wang, Wei-Hua Cai. Expression and function of myelin expression factor 2 in hepatocellular carcinomaBMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02644-3
80
Zhongqiang Qin, Fangquan Zhu, Bo Xie, Yang Zhang, Mu Yuan, Peipei Yang, Lan Zhang, Jianzhu Wei, Ziyi Zhu, Zhen Qian, Zhaoying Wang, Longfei Fan, Shuaishuai Xu, Yulin Tan, Jingyu Qian. Comprehensive analysis of ASB3 as a prognostic biomarker in hepatocellular carcinomaTranslational Oncology 2024; 39: 101816 doi: 10.1016/j.tranon.2023.101816
81
Zhihong Chen, Yiping Zou, Yuanpeng Zhang, Zhenrong Chen, Fan Wu, Ning Shi, Haosheng Jin. A novel prognostic signature based on four glycolysis‐related genes predicts survival and clinical risk of hepatocellular carcinomaJournal of Clinical Laboratory Analysis 2021; 35(11) doi: 10.1002/jcla.24005
82
Xiao Liu, Chiying Xiao, Kunyan Yue, Min Chen, Hang Zhou, Xiaokai Yan. Identification of multi-omics biomarkers and construction of the novel prognostic model for hepatocellular carcinomaScientific Reports 2022; 12(1) doi: 10.1038/s41598-022-16341-w
83
Pei-Yi Chu, Shih-Hsuan Chan. Cure the Incurable? Recent Breakthroughs in Immune Checkpoint Blockade for Hepatocellular CarcinomaCancers 2021; 13(21): 5295 doi: 10.3390/cancers13215295
84
Juncheng Wei, Deyu Fang. Endoplasmic Reticulum Stress Signaling and the Pathogenesis of HepatocarcinomaInternational Journal of Molecular Sciences 2021; 22(4): 1799 doi: 10.3390/ijms22041799
85
洪敬 刘. Advances in the Study of Micro-RNA inPrimary Liver CancerAdvances in Clinical Medicine 2018; 8(10): 963 doi: 10.12677/ACM.2018.810160
86
Jihan Huang, Feiyu Chen, Zhangfeng Zhong, Hor Yue Tan, Ning Wang, Yuting Liu, Xinyuan Fang, Tao Yang, Yibin Feng. Interpreting the Pharmacological Mechanisms of Huachansu Capsules on Hepatocellular Carcinoma Through Combining Network Pharmacology and Experimental EvaluationFrontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00414
87
Jue Wang, Zongrui Jin, Guolin Wu, Jilong Wang, Banghao Xu, Hai Zhu, Ya Guo, Zhang Wen, Surendiran B. Bioinformatics Analysis for Constructing a Six-Immune-Related Long Noncoding RNA Signature as a Prognostic Model of Hepatocellular CarcinomaBioMed Research International 2022; 2022: 1 doi: 10.1155/2022/2093437
88
Xueying Wang, Yangyu Zhang, Na Yang, Hua He, Xuerong Tao, Changgui Kou, Jing Jiang. Evaluation of the Combined Application of AFP, AFP-L3%, and DCP for Hepatocellular Carcinoma Diagnosis: A Meta-analysisBioMed Research International 2020; 2020: 1 doi: 10.1155/2020/5087643
89
Michael S Lee, Baek-Yeol Ryoo, Chih-Hung Hsu, Kazushi Numata, Stacey Stein, Wendy Verret, Stephen P Hack, Jessica Spahn, Bo Liu, Heba Abdullah, Yulei Wang, Aiwu Ruth He, Kyung-Hun Lee, Y-J Bang, J Bendell, Y Chao, J-S Chen, H C Chung, S L Davis, A Dev, E Gane, B George, A R He, H Hochster, C-H Hsu, M Ikeda, J Lee, M Lee, A Mahipal, G Manji, M Morimoto, K Numata, M Pishvaian, S Qin, D Ryan, B-Y Ryoo, N Sasahira, S Stein, J Strickler, N Tebbutt. Atezolizumab with or without bevacizumab in unresectable hepatocellular carcinoma (GO30140): an open-label, multicentre, phase 1b studyThe Lancet Oncology 2020; 21(6): 808 doi: 10.1016/S1470-2045(20)30156-X
90
Yue Zhao, Timothy Wai Ho Shuen, Tan Boon Toh, Xue Ying Chan, Min Liu, Sue Yee Tan, Yong Fan, Hechuan Yang, Shridhar Ganpathi Lyer, Glenn Kunnath Bonney, Eva Loh, Kenneth Tou En Chang, Thiam Chye Tan, Weiwei Zhai, Jerry Kok Yen Chan, Edward Kai-Hua Chow, Cheng Ean Chee, Guan Huei Lee, Yock Young Dan, Pierce Kah-Hoe Chow, Han Chong Toh, Seng Gee Lim, Qingfeng Chen. Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapyGut 2018; 67(10): 1845 doi: 10.1136/gutjnl-2017-315201
91
Vahid Mansouri, Nima Rezaei. Hepatobiliary Cancers: An Interdisciplinary ApproachInterdisciplinary Cancer Research 2022; 3: 1 doi: 10.1007/16833_2022_70
92
Tao Liu, Qiao Shi, Lei Yang, Shusen Wang, Hongli Song, Zhenglu Wang, Xinnv Xu, Hongsheng Liu, Hong Zheng, Zhongyang Shen. Long non-coding RNAs HERH-1 and HERH-4 facilitate cyclin A2 expression and accelerate cell cycle progression in advanced hepatocellular carcinomaBMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08714-7
93
Lun Wu, Jiao Zhou, Wenbo Zhou, Xue-Fei Huang, Qinhua Chen, Wei Wang, Lulu Zhai, Shengwei Li, Zhigang Tang. Sorafenib blocks the activation of the HIF-2α/VEGFA/EphA2 pathway, and inhibits the rapid growth of residual liver cancer following high-intensity focused ultrasound therapy in vivoPathology - Research and Practice 2021; 220: 153270 doi: 10.1016/j.prp.2020.153270
94
Yih-Jyh Lin, Chia-Ni Lin, Tannaz Sedghi, Sylvia H. Hsu, Cary P. Gross, Jung-Der Wang, Shi-Yi Wang, Nader Hanna. Treatment patterns and survival in hepatocellular carcinoma in the United States and TaiwanPLOS ONE 2020; 15(10): e0240542 doi: 10.1371/journal.pone.0240542
95
Kangjun Zhang, Taishi Fang, Dong Zhao, Fulan Cen, Xu Yan, Xin Jin. Circular RNA Circ_0008043 promotes the proliferation and metastasis of hepatocellular carcinoma cells by regulating the microRNA (miR)-326/RAB21 axisBioengineered 2022; 13(3): 6600 doi: 10.1080/21655979.2022.2044260
96
Jeannette Huaman, Cuong Bach, Adeodat Ilboudo, Olorunseun O. Ogunwobi. Precision Molecular Pathology of Liver CancerMolecular Pathology Library 2018; : 131 doi: 10.1007/978-3-319-68082-8_8
97
Fat-Moon Suk, Chao-Lien Liu, Ming-Hua Hsu, Yu-Ting Chuang, Jack P. Wang, Yi-Jen Liao. Treatment with a new benzimidazole derivative bearing a pyrrolidine side chain overcomes sorafenib resistance in hepatocellular carcinomaScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-53863-2
98
Bin Zhang, Yitao Liang, Liang Bo, Mingyu Chen, Bobo Huang, Qingpeng Cao, Jinwei Wei, Tianyu Li, Xiujun Cai, Xuesong Ye. A PCR-free screen-printed magnetic electrode for the detection of circular RNA from hepatocellular cancer based on a back-splice junctionRSC Advances 2021; 11(29): 17769 doi: 10.1039/D1RA01033F
99
Jelena Djokic Kovac, Tamara Milovanovic, Vladimir Dugalic, Igor Dumic. Pearls and pitfalls in magnetic resonance imaging of hepatocellular carcinomaWorld Journal of Gastroenterology 2020; 26(17): 2012-2029 doi: 10.3748/wjg.v26.i17.2012
100
Na Ryung Choi, Ju Yeon Kim, Ji Hoon Hong, Moon Haeng Hur, Heejin Cho, Min Kyung Park, Jihye Kim, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Jung-Hwan Yoon, Yoon Jun Kim. Comparison of the outcomes between sorafenib and lenvatinib as the first-line systemic treatment for HBV-associated hepatocellular carcinoma: a propensity score matching analysisBMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02210-3
101
Gokhan Yildiz. Integrated multi‑omics data analysis identifying novel drug sensitivity‑associated molecular targets of hepatocellular carcinoma cellsOncology Letters 2018;  doi: 10.3892/ol.2018.8634
102
Stefano Colagrande, Andrea Magnini, Lorenzo Cinci. Editorial for “Clinical‐Radiologic Morphology‐Radiomics Model on Gadobenate Dimeglumine‐Enhanced MRI for Identification of Highly Aggressive Hepatocellular Carcinoma: Temporal Validation and Multiscanner Validation”Journal of Magnetic Resonance Imaging 2024;  doi: 10.1002/jmri.29328
103
Yuchuan Jiang, Peng Chen, Kaishun Hu, Guanqi Dai, Jinying Li, Dandan Zheng, Hui Yuan, Lu He, Penghui Xie, Mengxian Tu, Shuang Peng, Chen Qu, Wenyu Lin, Raymond T. Chung, Jian Hong. Inflammatory microenvironment of fibrotic liver promotes hepatocellular carcinoma growth, metastasis and sorafenib resistance through STAT3 activationJournal of Cellular and Molecular Medicine 2021; 25(3): 1568 doi: 10.1111/jcmm.16256
104
Bin Zhang, Mingyu Chen, Jiasheng Cao, Yitao Liang, Tingting Tu, Jiahao Hu, Tianyu Li, Yu Cai, Shijie Li, Boqiang Liu, Junjie Xu, Bo Liang, Xuesong Ye, Xiujun Cai. An integrated electrochemical POCT platform for ultrasensitive circRNA detection towards hepatocellular carcinoma diagnosisBiosensors and Bioelectronics 2021; 192: 113500 doi: 10.1016/j.bios.2021.113500
105
Jasem Albarrak, Humaid Al-Shamsi. Current Status of Management of Hepatocellular Carcinoma in The Gulf Region: Challenges and RecommendationsCancers 2023; 15(7): 2001 doi: 10.3390/cancers15072001
106
Langqing Sheng, Jiarong Li, Nianfeng Li, Liansheng Gong, Ling Liu, Qi Zhang, Xiaoli Li, Hui Luo, Zeguo Chen. Atractylenolide III predisposes miR‐195‐5p/FGFR1 signaling axis to exert tumor‐suppressive functions in liver cancerJournal of Food Biochemistry 2021; 45(5) doi: 10.1111/jfbc.13582
107
Ya Li, Qiuju Han, Huajun Zhao, Quanjuan Guo, Jian Zhang. Napabucasin Reduces Cancer Stem Cell Characteristics in Hepatocellular CarcinomaFrontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.597520
108
Jiaying Wang, Yuting Miao, Lingmei Li, Yongqing Wu, Yan Ren, Yuehua Cui, Hongyan Cao. Multi-omics data integration for hepatocellular carcinoma subtyping with multi-kernel learningFrontiers in Genetics 2022; 13 doi: 10.3389/fgene.2022.962870
109
Guifu Xi, Runfen Cheng, Leiting Liang, Na Che, Yalei Wang, Nan Zhao, Xiaohui Liang, Bing Shao, Xiulan Zhao, Danfang Zhang. High expression of RNF31 is associated with tumor immune cell infiltration and leads to poor prognosis in liver hepatocellular carcinomaScientific Reports 2023; 13(1) doi: 10.1038/s41598-023-32692-4
110
Jiuwei Zhang, Yaodong Chen, Jing Lin, Ruimei Jia, Tingting An, Tianxiu Dong, Yu Zhang, Xiuhua Yang. Cyclovirobuxine D Exerts Anticancer Effects by Suppressing the EGFR-FAK-AKT/ERK1/2-Slug Signaling Pathway in Human Hepatocellular CarcinomaDNA and Cell Biology 2020; 39(3): 355 doi: 10.1089/dna.2019.4990